Guardian Pharmacy Services (GRDN) reported preliminary Q4 income Monday of $10.1 million to $11.1 million, down by $3.5 million to $4.5 million from a year earlier.
Three analysts polled by FactSet expect $10.5 million.
Revenue for the quarter ended Dec. 31 is expected to be $338.6 million, up 20.5% from a year earlier.
Three analysts surveyed by FactSet expect $320.5 million.
For 2025, the company expects revenue of $1.33 billion to $1.35 billion. Three analysts polled by FactSet expect $1.33 billion.
Shares of the company were down nearly 10% in recent premarket activity.
Price: 18.01, Change: -1.99, Percent Change: -9.95
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.